Inovio Pharmaceuticals Inc Stock Price and Quote (2024)

Held by: VTI VXF VHT AVSC GERM BTEC QQQS

Scroll to Statements

Index	-	P/E	-	EPS (ttm)	-6.11	Insider Own	1.65%	Shs Outstand	23.37M	Perf Week	15.92%
Market Cap	289.32M	Forward P/E	-	EPS next Y	-2.96	Insider Trans	0.00%	Shs Float	22.98M	Perf Month	51.72%
Income	-135.12M	PEG	-	EPS next Q	-0.99	Inst Own	17.93%	Short Float	8.08%	Perf Quarter	132.36%
Sales	0.83M	P/S	348.58	EPS this Y	36.75%	Inst Trans	54.59%	Short Ratio	3.48	Perf Half Y	175.11%
Book/sh	5.15	P/B	2.40	EPS next Y	23.29%	ROA	-51.59%	Short Interest	1.86M	Perf Year	7.19%
Cash/sh	6.22	P/C	1.99	EPS next 5Y	41.50%	ROE	-79.55%	52W Range	3.89 - 12.79	Perf YTD	102.29%
Dividend Est.	-	P/FCF	-	EPS past 5Y	13.49%	ROI	-105.25%	52W High	-3.21%	Beta	1.08
Dividend TTM	-	Quick Ratio	3.60	Sales past 5Y	60.80%	Gross Margin	-321.09%	52W Low	218.42%	ATR (14)	0.99
Dividend Ex-Date	-	Current Ratio	3.60	EPS Y/Y TTM	57.05%	Oper. Margin	-16036.65%	RSI (14)	71.32	Volatility	8.39% 10.29%
Employees	122	Debt/Eq	0.26	Sales Y/Y TTM	-91.89%	Profit Margin	-16239.85%	Recom	2.20	Target Price	19.25
Option/Short	Yes / Yes	LT Debt/Eq	0.09	EPS Q/Q	56.92%	Payout	-	Rel Volume	1.10	Prev Close	12.40
Sales Surprise	-71.39%	EPS Surprise	7.25%	Sales Q/Q	-17.66%	Earnings	Mar 06 AMC	Avg Volume	534.48K	Price	12.38
SMA20	19.04%	SMA50	47.93%	SMA200	100.16%	Trades		Volume	590,167	Change	-0.16%

open in yahoo|&nbspopen in reuters|&nbspopen in marketwatch|&nbspopen in google|&nbspopen in EDGAR

Inovio Pharmaceuticals Inc Stock Price and Quote (1)

Inovio Pharmaceuticals Inc Stock Price and Quote (2)

Date	Action	Analyst	Rating Change	Price Target Change
Jan-25-24	Upgrade	Oppenheimer	Perform → Outperform	$4
Nov-09-22	Downgrade	Maxim Group	Buy → Hold
Nov-01-22	Downgrade	BofA Securities	Neutral → Underperform	$2
Jul-19-22	Resumed	RBC Capital Mkts	Sector Perform	$5 → $4
May-11-22	Downgrade	Oppenheimer	Outperform → Perform
Jan-21-22	Upgrade	BofA Securities	Underperform → Neutral	$8 → $10
Dec-29-21	Resumed	Jefferies	Hold	$8 → $6
Sep-10-21	Downgrade	BofA Securities	Neutral → Underperform	$9 → $8
Jun-24-21	Initiated	Jefferies	Hold	$9
Mar-23-21	Initiated	BofA Securities	Neutral	$13
Feb-12-21	Initiated	Oppenheimer	Outperform	$35
Nov-17-20	Downgrade	ROTH Capital	Neutral → Sell
Nov-10-20	Upgrade	ROTH Capital	Sell → Neutral	$8
Sep-28-20	Upgrade	Maxim Group	Hold → Buy	$20
Sep-28-20	Downgrade	Cantor Fitzgerald	Overweight → Neutral
Jul-01-20	Downgrade	ROTH Capital	Neutral → Sell	$11
Jul-01-20	Downgrade	Maxim Group	Buy → Hold
Jun-29-20	Downgrade	H.C. Wainwright	Buy → Neutral
Jun-26-20	Downgrade	Stifel	Buy → Hold	$19 → $24
May-21-20	Initiated	The Benchmark Company	Buy	$28

Show Previous Ratings

Inovio Pharmaceuticals Inc Stock Price and Quote (3)

Today 06:28PM	INOVIO to Participate in The Citizens JMP Novel Therapeutics Forum at Penn Medicine (PR Newswire)
Mar-08-24 09:55AM	Does Inovio (INO) Have the Potential to Rally 122.92% as Wall Street Analysts Expect? (Zacks) +12.74%
Mar-07-24 10:38AM	Inovio Pharmaceuticals, Inc. (NASDAQ:INO) Q4 2023 Earnings Call Transcript (Insider Monkey) -8.51%
06:39AM	Q4 2023 Inovio Pharmaceuticals Inc Earnings Call (Thomson Reuters StreetEvents)
Mar-06-24 11:30PM	Inovio Pharmaceuticals (INO) Q4 2023 Earnings Call Transcript (Motley Fool)
09:54PM	INO Stock Earnings: Inovio Pharmaceuticals Beats EPS, Misses Revenue for Q4 2023 (InvestorPlace)
04:05PM	INOVIO Reports Fourth Quarter and Full Year 2023 Financial Results and Operational Highlights (PR Newswire)
07:00AM	Geneos Therapeutics to Present New Clinical Data on GNOS-PV02 at the 2024 American Association for Cancer Research (AACR) Annual Meeting (PR Newswire)
Feb-21-24 09:55AM	Wall Street Analysts Predict a 146.39% Upside in Inovio (INO): Here's What You Should Know (Zacks)
08:00AM	INOVIO to Report Fourth Quarter and Year-End 2023 Financial Results on March 6, 2024 (PR Newswire)
Feb-12-24 06:25AM	Inovio (INO) Moves 17.4% Higher: Will This Strength Last? (Zacks) +5.64%
Feb-07-24 11:46AM	INOVIO to Present at the Oppenheimer 34th Annual Healthcare Life Sciences Conference (PR Newswire)
Feb-02-24 08:00AM	INOVIO Reports Inducement Grant Under Inducement Plan (PR Newswire) -5.08%
Jan-30-24 09:55AM	How Much Upside is Left in Inovio (INO)? Wall Street Analysts Think 223.72% (Zacks) -6.25%
Jan-24-24 09:13AM	Why Is Inovio Pharmaceuticals (INO) Stock Down Today? (InvestorPlace)
Jan-23-24 08:00AM	INOVIO Announces Effective Date of 1-for-12 Reverse Stock Split (PR Newswire) -16.15%
Jan-22-24 08:00AM	INOVIO to Participate in Virtual Fireside Chat on the Potential Treatment of Recurrent Respiratory Papillomatosis with Key Opinion Leader (PR Newswire)
Jan-12-24 09:43AM	Inovio Pharma (INO) Stock Rallies 134% in a Month: Here's Why (Zacks) -12.99%
Jan-04-24 08:00AM	INOVIO and Coherus Announce Clinical Collaboration to Advance Development of INO-3112 in Combination with LOQTORZI (toripalimab-tpzi) (PR Newswire) +9.97%
Jan-03-24 08:00AM	INOVIO Plans to Submit a BLA for INO-3107 as a Potential Treatment for RRP in Second Half of 2024 Under Accelerated Approval Program (PR Newswire) -7.70%
Nov-14-23 10:56AM	The 3 Most Undervalued Biotech Stocks to Buy: November 2023 (InvestorPlace) +7.14%
Nov-10-23 03:38PM	Inovio Pharmaceuticals, Inc. (NASDAQ:INO) Q3 2023 Earnings Call Transcript (Insider Monkey)
12:00AM	Inovio Pharmaceuticals (INO) Q3 2023 Earnings Call Transcript (Motley Fool)
Nov-09-23 04:42PM	Inovio: Q3 Earnings Snapshot (Associated Press Finance)
04:05PM	INOVIO Reports Third Quarter 2023 Financial Results and Operational Highlights (PR Newswire)
Nov-01-23 08:00AM	INOVIO Reports Inducement Grants Under Inducement Plan (PR Newswire)
Oct-26-23 08:00AM	INOVIO to Report Third Quarter 2023 Financial Results on November 9, 2023 (PR Newswire)
Oct-19-23 09:53AM	Inovio Pharma (INO) Stock Surges 19% This Month: Here's Why (Zacks)
Oct-10-23 08:00AM	INOVIO Receives FDA Feedback that Data from Completed Phase 1/2 Trial of INO-3107 Can Be Used to Submit a BLA Under Accelerated Approval Program (PR Newswire) +41.00%
Sep-28-23 11:10AM	Inovio spinoff Geneos raises another $5M to advance therapeutic cancer vaccines (American City Business Journals)
Sep-27-23 07:39PM	Geneos Therapeutics Closes its Series A3 Financing With Investment of $5 Million (PR Newswire)
Sep-07-23 08:00AM	INOVIO Announces U.S. FDA Breakthrough Therapy Designation Granted for INO-3107 for the Treatment of Recurrent Respiratory Papillomatosis (PR Newswire)
Sep-06-23 09:31PM	Philadelphia-area life sciences firms have now cut more than 500 jobs since the start of 2022 (American City Business Journals) -5.52%
Aug-29-23 08:00AM	INOVIO to Present at the H.C. Wainwright 25th Annual Global Investment Conference (PR Newswire) +8.35%
Aug-09-23 08:30PM	Inovio Pharmaceuticals (INO) Q2 2023 Earnings Call Transcript (Motley Fool)
05:40PM	Inovio Pharmaceuticals (INO) Reports Q2 Loss, Tops Revenue Estimates (Zacks)
04:38PM	Inovio: Q2 Earnings Snapshot (Associated Press Finance)
04:05PM	INOVIO Announces Second Quarter 2023 Financial Results and Provides Strategic Update (PR Newswire)
Aug-04-23 08:00AM	INOVIO Reports Inducement Grants Under Inducement Plan (PR Newswire)
Jul-26-23 09:32AM	INOVIO to Report Second Quarter 2023 Financial Results on August 9, 2023 (PR Newswire)
Jun-23-23 04:10PM	INOVIO Announces Notice of Pendency and Proposed Settlement of Stockholder Derivative Actions (GlobeNewswire)
Jun-01-23 08:00AM	INOVIO Reports Inducement Grants Under Inducement Plan (PR Newswire)
May-25-23 08:00AM	INOVIO to Present at the 2023 Jefferies Healthcare Conference (PR Newswire)
May-23-23 04:13PM	INOVIO Announces Orphan Drug Designation for INO-3107 for the Treatment of Recurrent Respiratory Papillomatosis from the European Commission (PR Newswire)
May-15-23 12:00PM	All You Need to Know About Inovio (INO) Rating Upgrade to Buy (Zacks) +5.14%
06:08AM	These Analysts Think Inovio Pharmaceuticals, Inc.'s (NASDAQ:INO) Sales Are Under Threat (Simply Wall St.)
May-13-23 08:20AM	Analysts Have Lowered Expectations For Inovio Pharmaceuticals, Inc. (NASDAQ:INO) After Its Latest Results (Simply Wall St.)
May-12-23 06:14AM	Inovio Pharmaceuticals First Quarter 2023 Earnings: Misses Expectations (Simply Wall St.) -6.89%
May-11-23 03:30AM	Inovio Pharmaceuticals (INO) Q1 2023 Earnings Call Transcript (Motley Fool)
May-10-23 05:45PM	Inovio Pharmaceuticals (INO) Reports Q1 Loss, Misses Revenue Estimates (Zacks)
04:05PM	INOVIO Reports First Quarter 2023 Financial Results and Operational Highlights (PR Newswire)
May-08-23 08:00AM	New Data from Phase 1/2 Trial of INO-3107 for the Treatment of Recurrent Respiratory Papillomatosis Presented at ABEA during COSM 2023 (PR Newswire)
May-05-23 08:00AM	INOVIO to Present at the 2023 RBC Capital Markets Global Healthcare Conference (PR Newswire)
Apr-28-23 08:00AM	INOVIO to Report First Quarter 2023 Financial Results on May 10, 2023 (PR Newswire)
Apr-27-23 08:00AM	INOVIO Announces Acceptance of Abstract for Oral Presentation on INO-3107 for the Treatment of Recurrent Respiratory Papillomatosis at COSM 2023 (PR Newswire)
Apr-26-23 08:00AM	European Committee for Orphan Medicinal Products Provides Positive Opinion on INOVIO's Application for Orphan Drug Designation for INO-3107 (PR Newswire)
Apr-17-23 01:55PM	These 3 Nasdaq Stocks Are on Fire Today: Here's Why (Motley Fool) +9.83%
08:00AM	Data from Phase 1b trial with INO-4201 as an Ebola Booster for rVSV-ZEBOV (Ervebo®) presented at ECCMID 2023 (PR Newswire)
Apr-13-23 02:07PM	Why Inovio Pharmaceuticals' Shares Jumped on Thursday (Motley Fool) +27.53%
Apr-12-23 08:00AM	INOVIO Announces Acceptance of Abstract for Oral Presentation on INO-4201 as an Ebola Booster for rVSV-ZEBOV (Ervebo®) at ECCMID 2023 (PR Newswire)
Apr-04-23 03:10PM	Why Shares of Inovio Pharmaceuticals Were Down Tuesday (Motley Fool) -8.22%
Apr-03-23 08:00AM	INOVIO Reports Inducement Grant Under Inducement Plan (PR Newswire)
Mar-06-23 01:07AM	Inovio Pharmaceuticals, Inc. (NASDAQ:INO) Q4 2022 Earnings Call Transcript (Insider Monkey) -8.33%
Mar-03-23 08:00AM	INOVIO to Present at the Oppenheimer 33rd Annual Healthcare Conference (PR Newswire)
Mar-01-23 07:00PM	Inovio Pharmaceuticals (INO) Q4 2022 Earnings Call Transcript (Motley Fool)
06:15PM	Inovio Pharmaceuticals (INO) Reports Q4 Loss, Lags Revenue Estimates (Zacks)
04:05PM	INOVIO Reports Fourth Quarter and Full Year 2022 Financial Results and Clinical Highlights (PR Newswire)
Feb-16-23 08:00AM	INOVIO Announces Positive Preliminary Results from Second Cohort of Phase 1/2 Trial with INO-3107 for the Treatment of Recurrent Respiratory Papillomatosis (PR Newswire)
Feb-15-23 08:00AM	INOVIO to Report Fourth Quarter and Year-End 2022 Financial Results on March 1, 2023 (PR Newswire)
Feb-03-23 08:00AM	INOVIO Reports Inducement Grants Under Inducement Plan (PR Newswire) +6.70%
Feb-02-23 01:39PM	Inovio Pharma Releases Favorable Data From Booster DNA Vaccine Candidate For Ebola (Benzinga) +7.19%
08:00AM	INOVIO Reports Positive Phase 1b Results for INO-4201 as an Ebola Booster for rVSV-ZEBOV (Ervebo®) (PR Newswire)
Feb-01-23 01:55PM	3 Sorry Pharma Stocks to Sell in February Before Its Too Late (InvestorPlace)
Jan-31-23 11:40AM	Inovio Pharmaceuticals enacts its second round of layoffs in just over six months (American City Business Journals)
11:07AM	INOVIO Announces Further Reorganization, Continues Focus on Promising DNA Candidates (Benzinga)
08:00AM	INOVIO Announces Strategic Reorganization, Continues Efforts to Focus on Promising DNA Medicine Candidates (PR Newswire)
Jan-03-23 07:27AM	Inovio Pharmaceuticals (NASDAQ:INO) adds US$37m to market cap in the past 7 days, though investors from a year ago are still down 69% (Simply Wall St.)
Nov-18-22 11:42AM	Within A Month After Pulling Plug On COVID-19 Booster Study, Inovio Shelves Two More Infectious Disease Programs (Benzinga) -8.97%
11:02AM	Inovio shares fall on discontinuation of development of two more vaccine candidates (American City Business Journals)
Nov-17-22 04:30PM	INOVIO Provides an Update on Lassa Fever and MERS Programs (PR Newswire)
09:23AM	3 Stocks to Avoid Right Now (Motley Fool)
Nov-08-22 10:00PM	Inovio Pharmaceuticals (INO) Q3 2022 Earnings Call Transcript (Motley Fool)
06:25PM	Inovio Pharmaceuticals (INO) Reports Q3 Loss, Tops Revenue Estimates (Zacks)
04:57PM	What's Going On With Inovio Pharmaceuticals Stock Tuesday After Hours (Benzinga)
04:05PM	INOVIO Reports Financial Results and Highlights for the Third Quarter 2022 (PR Newswire)
Oct-28-22 04:27PM	Why Inovio Pharmaceuticals Stock Zoomed Nearly 6% Higher Today (Motley Fool) +7.28%
12:37PM	Inovio Pharma Stops Work On INO-4800 As COVID-19 Heterologous Booster (Benzinga)
08:50AM	Inovio discontinues efforts to develop Covid-19 vaccine booster (American City Business Journals)
Oct-27-22 04:30PM	INOVIO Provides Update on COVID-19 Heterologous Booster Vaccine Candidate, INO-4800 (PR Newswire)
Oct-26-22 10:41AM	Strength Seen in Immunocore Holdings PLC Sponsored ADR (IMCR): Can Its 10.2% Jump Turn into More Strength? (Zacks)
Oct-25-22 08:00AM	INOVIO to Report Third Quarter 2022 Financial Results on November 8, 2022 (PR Newswire) +9.30%
Oct-21-22 06:02PM	Inovio Pharmaceuticals, Inc. stock performance and analyst projections (Yahoo Finance Video) +7.93%
Oct-17-22 05:59PM	Why Inovio Pharmaceuticals' Shares Jumped 17.31% on Monday (Motley Fool) +17.31%
Oct-13-22 10:30AM	Inovio Pharma Highlights Early Data From Experimental Drug For Respiratory Tract Disease (Benzinga)
08:00AM	INOVIO Reports Positive Interim Phase 1/2 Results for INO-3107 for the Treatment of Recurrent Respiratory Papillomatosis (PR Newswire)
Sep-25-22 09:05AM	Institutions along with individual investors who hold considerable shares inInovio Pharmaceuticals, Inc. (NASDAQ:INO) come under pressure; lose 11% of holdings value (Simply Wall St.)
Sep-11-22 10:53AM	1 Green Flag and 1 Red Flag For Inovio Pharmaceuticals (Motley Fool)
Sep-07-22 10:12AM	Emergent (EBS) Initiates Study on Lassa Virus Vaccine Candidate (Zacks)
Sep-01-22 08:00AM	INOVIO Reports Inducement Grants Under Inducement Plan (PR Newswire)
Aug-30-22 08:00AM	INOVIO to Present at the H.C. Wainwright 24th Annual Global Investment Conference (PR Newswire)

Inovio Pharmaceuticals Inc Stock Price and Quote (4)

Inovio Pharmaceuticals, Inc. engages in the provision of designed DNA medicines to treat and protect people from infectious diseases, cancer, and diseases associated with human papillomavirus. Its product pipeline includes VGX-3100, INO-3107, INO-5410, INO-4800, and PENNVAX-GP. The company was founded by David B. Weiner on June 29, 1983 and is headquartered in Plymouth Meeting, PA.

Inovio Pharmaceuticals Inc Stock Price and Quote (5)

Inovio Pharmaceuticals Inc Stock Price and Quote (6)

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Zoth Lota S.	Director	Jun 05 '23	Sale	0.56	5,700	3,192	52,716	Jun 05 04:13 PM

Upgrade your FINVIZ experience

Join thousands of traders who make more informed decisions withourpremium features. Real-time quotes, advancedvisualizations, backtesting, and much more.

Learn more about FINVIZ*Elite

FAQs

Is Inovio a good buy right now? ›

Inovio Pharmaceuticals's analyst rating consensus is a Moderate Buy.

Find Out More ›

Why is INO stock dropping? ›

Inovio Pharmaceuticals (INO) stock is dropping on Wednesday after announcing a reverse stock split. That will see it consolidate 12 shares into a single share.

High	$40.00
Median	$14.50
Low	$8.00
Average	$19.25
Current Price	$10.02

Why is Inovio stock up today? ›

Inovio's stock is up after it shares new data from Phase 2 clinical trial for its COVID-19 vaccine candidate.

Learn More Now ›

Which share is best for 2030? ›

Target 2030

S.No.	Name	CMP Rs.
1.	PCBL Ltd	266.75
2.	L T Foods	215.20
3.	Harsha Engg Intl	422.10
4.	Sarda Energy	224.25

18 more rows

Learn More Now ›

Who owns Inovio? ›

Who owns the most shares of Inovio Pharmaceuticals (INO)? VANGUARD INDEX FUNDS owns the most shares of Inovio Pharmaceuticals (INO).

Get More Info ›

Who owns Inovio Pharmaceuticals? ›

Largest shareholders include Price T Rowe Associates Inc /md/, Simplex Trading, Llc, Tudor Investment Corp Et Al, Green Alpha Advisors, LLC, PRFZ - Invesco FTSE RAFI US 1500 Small-Mid ETF, SWTSX - Schwab Total Stock Market Index Fund, Cedar Brook Financial Partners, LLC, Farther Finance Advisors, LLC, Simplex Trading, ...

Find Out More ›

Who owns Inovio stock? ›

Inovio Pharmaceuticals (NASDAQ: INO) is owned by 214.70% institutional shareholders, 134.08% Inovio Pharmaceuticals insiders, and 0.00% retail investors. Austin W. Greenhouse David M. Marxe is the largest individual Inovio Pharmaceuticals shareholder, owning 20.65M shares representing 88.36% of the company.

Find Out More ›

How high is Inovio stock expected to go? ›

Based on short-term price targets offered by four analysts, the average price target for Inovio Pharmaceuticals comes to $17.75. The forecasts range from a low of $8.00 to a high of $40.00.

Know More ›

What is the stock price forecast for INO in 2024? ›

Inovio Stock Price Forecast 2024-2025

Inovio price started in 2024 at $6.92. Today, Inovio traded at $9.68, so the price increased by 40% from the beginning of the year. The forecasted Inovio price at the end of 2024 is $24.36 - and the year to year change +252%. The rise from today to year-end: +152%.

Discover More ›